Victory Capital Management
FRTX

Victory Capital Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Victory Capital Management’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-354
Closed -$2K – 2802
2022
Q2 		$2K Buy
354
+10
+3% +$91 ﹤0.01% 2689
2022
Q1 		$3K Sell
344
-6
-2% -$65 ﹤0.01% 2718
2021
Q4 		$4K Buy
350
+78
+29% +$1.4K ﹤0.01% 2758
2021
Q3 		$9K Buy
272
+41
+18% +$1.33K ﹤0.01% 2764
2021
Q2 		$10K Sell
231
-5
-2% -$206 ﹤0.01% 2732
2021
Q1 		$12K Buy
+236
New +$13K ﹤0.01% 2739
2020
Q2 		– Sell
-55
Closed -$2K – 3447
2020
Q1 		$2K Buy
+55
New +$4.3K ﹤0.01% 3700
2019
Q4 		– Sell
-11
Closed -$2K – 3436
2019
Q3 		$2K Buy
+11
New +$2.53K ﹤0.01% 3666

Other funds holding FRTX

TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management's FRTX Position: Q3 2022 in Review

Victory Capital Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2022, closing a stake of 354 shares — an estimated $2K sold.

Victory Capital Management first reported a position in FRTX in Q3 2019 and held it in 8 quarters. The position peaked at $12K in Q1 2021. 17 funds tracked by Wall St. Rank hold FRTX as of Q3 2022.

  • Victory Capital Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Victory Capital Management sold 354 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2K.
  • Victory Capital Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2019 and held it in 8 quarters.
  • Victory Capital Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $12K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Victory Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.